主页
市场
图表与思路
Algo
新闻
Store
经纪商
下载
经济日历
交易信号
网页端
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
URGN
#2066
UroGen Pharma Ltd. Ordinary Shares
21.700
0
+4.28%
版块:
基础:
利润货币:
日范围
年范围
日变化
+4.28%
每月变动
-0.60%
6个月变化
+14.21%
年变化
+14.21%
前一天收盘价
20.810
0
Open
21.700
0
Bid
Ask
Low
21.700
0
High
21.700
0
交易量
74
市场
股票
医疗保健
URGN
Open full chart
Financials
Overview
声明
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
22.27 M
22.67 M
23.44 M
34.12 M
46.09 M
—
Valuation ratios
Enterprise value
348.49 M
171.21 M
147.12 M
423.99 M
318.92 M
2.11 B
Price to earnings ratio
—
—
1.79
4.29
3.6
16.97
Price to sales ratio
—
—
3.06
5.3
5.05
26.8
Price to cash flow ratio
—
—
2.25
5.74
4.72
21.28
Price to book ratio
—
—
2.21
6.73
51.87
63.46
Enterprise value to EBITDA ratio
-2.75
-1.87
-1.88
-6.55
-3.3
-17.73
Profitability ratios
Return on assets %
-1.05
-0.93
-0.81
-0.57
-0.44
-0.73
Return on equity %
-1.33
-13.17
-1.23
-1.57
-14.41
-6.03
Return on invested capital %
-1 235.54
-2 006.82
-1 488.99
-1 069.42
-1 457.96
-1 937.33
Gross margin %
91.45
89.27
88.11
88.68
90.18
351.85
Operating margin %
-1 074.15
-192.11
-122.82
-79.23
-107.06
-565.66
EBITDA margin %
-1 074.29
-190.44
-121.42
-78.27
-106.77
-568.25
Net margin %
-1 088.94
-230.67
-170.58
-123.61
-140.35
-696.75
Liquidity ratios
Quick ratio
5.3
4.9
5.21
5.24
5.81
19.06
Current ratio
5.39
5.11
5.39
5.42
6.01
19.79
Inventory turnover
—
—
0.19
0
—
—
Asset turnover
0.07
0.4
0.5
0.53
0.39
0.41
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
0.72
0.55
0.43
2.17
Long term debt to total equity ratio
—
—
-1.09
-1.51
-13.83
-18.83
Per share metrics
Operating cash flow per share
—
—
-3.84
-2.65
-2.26
-2.89
EBIT per share
—
—
-3.47
-2.27
-2.26
-2.82
EBITDA per share
—
—
-3.43
-2.25
-2.25
-2.82
Total debt per share
—
—
—
—
—
—
Cash per share
—
—
4.38
4.91
5.64
15.4
Net current asset value per share
—
—
5.65
5.87
6.44
18.5
Tangible book value per share
—
—
-3.92
-2.26
-0.21
-5.52
Working capital per share
—
—
4.6
4.79
5.37
14.77
Book value per share
—
—
-3.92
-2.26
-0.21
-5.52
新闻
UroGen Pharma首席医疗官Schoenberg出售价值14.5万美元股份
UroGen Pharma CMO Schoenberg sells $145k in shares
enGene Holdings: A Potential Oncology Entrant (NASDAQ:ENGN)
2025 Performance Review And Future Strategy
UroGen Pharma股票创52周新高,达25.2美元
Urogen Pharma Ltd stock hits 52-week high at 25.2 USD
UroGen Pharma在古根海姆会议上:UGN-102上市的战略洞察
UroGen Pharma at Guggenheim Conference: Strategic Insights into UGN-102 Launch
Urogen Pharma股价创52周新高达23.66美元
Urogen Pharma stock hits 52-week high at 23.66 USD
UroGen Pharma Ltd. (URGN) Q3 2025 Earnings Call Transcript
UroGen Pharma股价在三期临床试验取得积极结果后大涨